Amplitude Vascular Systems
Amplitude Vascular Systems (AVS) is a medical device company focused on safely and effectively treating severely calcified arterial disease using its novel PULSE IVL™ platform. The company's PULSE IVL™ System is an investigational device designed to improve patient outcomes by addressing calcified arterial disease. AVS is currently conducting several IDE trials for its device in the US.
Funding Round: Series B
Funding Amount: $36M
Date: 28-Jan-2025
Investors: BioStar Capital, Cue Growth Partners
Markets: Medtech, Cardiovascular, Health Care, Medical, Medical Device
HQ: Boston, Massachusetts, United States
Founded: 2017
Website: https://www.avspulse.com/
LinkedIn: https://www.linkedin.com/company/avspulse
Twitter: https://twitter.com/AVS_PIVL
Crunchbase: https://www.crunchbase.com/organization/amplitude-vascular-systems
Leave a Comment
Comments
No comments yet.